These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7507748)

  • 41. [Lobular carcinoma in situ of the breast].
    Llanos Muñoz M; Alonso Muñoz MC; Ojeda González B
    Med Clin (Barc); 1994 Oct; 103(14):553-6. PubMed ID: 7799670
    [No Abstract]   [Full Text] [Related]  

  • 42. E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions.
    Goldstein NS; Bassi D; Watts JC; Layfield LJ; Yaziji H; Gown AM
    Am J Clin Pathol; 2001 Apr; 115(4):534-42. PubMed ID: 11293901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Morphology, topography and growth pattern of benign proliferative breast lesions and pre-invasive cancers].
    Böcker W; Jarasch ED; Nagle EB; Höhne R
    Verh Dtsch Ges Pathol; 1985; 69():96-107. PubMed ID: 3006396
    [No Abstract]   [Full Text] [Related]  

  • 45. Pathology of the breast.
    Litzky LA
    Semin Roentgenol; 1993 Jul; 28(3):259-67. PubMed ID: 8211234
    [No Abstract]   [Full Text] [Related]  

  • 46. [Significance of hyperelastosis in proliferative lesions of the breast].
    Cuccurullo L; Giordano GG; Mineo A; Iaccarino M; Battista O; Cattaneo L; Ferraraccio F
    Pathologica; 1984; 76(1041):89-101. PubMed ID: 6087264
    [No Abstract]   [Full Text] [Related]  

  • 47. Core biopsy of nodular adenosis of the breast can lead to underdiagnosis.
    Westenend PJ; Liem SJ
    AJR Am J Roentgenol; 2001 Jun; 176(6):1596. PubMed ID: 11373239
    [No Abstract]   [Full Text] [Related]  

  • 48. [Molecular biology of preinvasive and invasive breast tumors].
    Zikán M; Pavlista D; Velenská Z; Cibula D
    Ceska Gynekol; 2008 Dec; 73(6):351-5. PubMed ID: 19170369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Value of cytokeratin 5/6 immunostaining using D5/16 B4 antibody in the spectrum of proliferative intraepithelial lesions of the breast. A comparative study with 34betaE12 antibody.
    Lacroix-Triki M; Mery E; Voigt JJ; Istier L; Rochaix P
    Virchows Arch; 2003 Jun; 442(6):548-54. PubMed ID: 12712335
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Immunocytochemical demonstration of actin in myothelial cells in proliferative diseases of the breast].
    Walther B; Rutter G; Stegner HE; Böcker W
    Pathologe; 1986 Nov; 7(6):318-23. PubMed ID: 3027685
    [No Abstract]   [Full Text] [Related]  

  • 51. Objective quantitative grading. A study of breast ductal hyperplasias and ductal carcinomas in situ.
    Mariuzzi G; Mombello A; Mariuzzi L; Thompson D; Bartels PH
    Ann N Y Acad Sci; 1996 Apr; 784():395-402. PubMed ID: 8651587
    [No Abstract]   [Full Text] [Related]  

  • 52. Localization and quantitation of expression of the cell motility-related protein thymosin beta15 in human breast tissue.
    Gold JS; Bao L; Ghoussoub RA; Zetter BR; Rimm DL
    Mod Pathol; 1997 Nov; 10(11):1106-12. PubMed ID: 9388061
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Definition and development of "borderline" lesions in breast cancer. Atypical hyperplasia and carcinoma "in situ"].
    Contesso G
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):101-2. PubMed ID: 7451846
    [No Abstract]   [Full Text] [Related]  

  • 54. Atypical cystic lobules in patients with lobular neoplasia.
    Brogi E; Oyama T; Koerner FC
    Int J Surg Pathol; 2001 Jul; 9(3):201-6. PubMed ID: 11584316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atypical cystic lobules: an early stage in the formation of low-grade ductal carcinoma in situ.
    Oyama T; Maluf H; Koerner F
    Virchows Arch; 1999 Oct; 435(4):413-21. PubMed ID: 10526005
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cystic hypersecretory carcinoma with microinvasive carcinoma and cystic hypersecretory hyperplasia of breast: report of a case].
    Chen DB; Kan X
    Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):54-5. PubMed ID: 20388402
    [No Abstract]   [Full Text] [Related]  

  • 57. The histology of fibrocystic disease of the female breast. Correlation with epithelial proliferative lesions and carcinoma in situ.
    Anastassiades OT; Tsakraklides E; Gogas J
    Pathol Res Pract; 1981 Jul; 172(1-2):109-29. PubMed ID: 7312702
    [No Abstract]   [Full Text] [Related]  

  • 58. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part II: Epitheliosis and ductal carcinoma in situ.
    Böcker W; Bier B; Freytag G; Brömmelkamp B; Jarasch ED; Edel G; Dockhorn-Dworniczak B; Schmid KW
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(4):323-30. PubMed ID: 1384227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of hyaluronan in benign and malignant breast lesions.
    Auvinen PK; Parkkinen JJ; Johansson RT; Agren UM; Tammi RH; Eskelinen MJ; Kosma VM
    Int J Cancer; 1997 Oct; 74(5):477-81. PubMed ID: 9355968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytokeratin intermediate filament expression in benign and malignant breast disease.
    Heatley M; Maxwell P; Whiteside C; Toner P
    J Clin Pathol; 1995 Jan; 48(1):26-32. PubMed ID: 7535804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.